Longitudinal digital-therapeutics patient program panel

Longitudinal digital-therapeutics patient program panel: enrollment-to-persistence journey events across eight therapeutic areas, with patient-reported outcomes and symptom/adverse-event reports, ecological-momentary assessment responses, app engagement telemetry (session, reminder response, module completion), biometric/peak-flow and connected-device readings, and stage-level abandonment/discontinuation outcome labels with attributed reasons (cost-sharing, coverage/prior-authorization, therapy change, perceived efficacy, tolerance).

Open buyer room →

Sample

Brickroad customers

Sample this dataset before you buy it.

Your sourcing agent asks BrightInsight and files the sample in your catalog — private to you.

Start 7-day trialNothing is charged until the trial ends.

Coverage

Universe, instruments and categories.

Industry: Health Care Technology
Instruments: equities
Categories: AlternativeSentimentFundamental
Regions: US
Sample tickers: AMGNREGNLLYJNJABBVBMYNVOAZN

Dataset card

Type: not stated
Format: Multimodal — event-log telemetry from a mobile app, structured tabular patient-reported outcome and biometric readings, free-text symptom/adverse-event entries, and joined tabular journey/outcome tables
Volume: Est. tens of millions of engagement events and hundreds of thousands to millions of patient-reported assessment responses (reasoning: several scheduled assessments, reminders and check-ins per enrolled patient per month across multi-month programs, multiplied by enrolled cohorts in eight therapeutic areas)
Users: Est. low-to-mid hundreds of thousands of enrolled patients across sponsor programs (inferred from ~150 employees, ~$179M raised, and programs spanning eight therapeutic areas with enterprise pharma customers)
History: 10 years
Update frequency: not stated
Growth: Active — publishing ongoing co-branded research, running a demo request funnel and a careers page, and expanding the portfolio into Software as a Medical Device products
Launched: est. 2012-2015 for the digital medicine platform (a company with ~$179M raised and ~150 staff pre-dates the recent digital-therapeutics wave); the SaMD product line is later, est. 2021-2024
Delivery: not stated
Entity mapping: not stated
Sample: not stated
Point-in-time: not stated
Licence: not stated

supplier index read from their site

BrightInsight has not added their own details yet. Not yet on file:

Dataset
Data dictionary
Coverage
Provenance
Rights & data handling